Science / Reel
Science · Video brief
The mRNA technology behind Moderna’s Covid vaccine reaches the flu
The FDA has approved Moderna's new mRNA flu vaccine, mFlusiva, specifically for adults aged 50 and older. In trials, it demonstrated a 27% reduction in flu cases, offering a promising tool to tackle evolving flu mutations.
Video won't play? Watch on YouTube →
The FDA has approved Moderna's new mRNA flu vaccine, mFlusiva, specifically for adults aged 50 and older. In trials, it demonstrated a 27% reduction in flu cases, offering a promising tool to tackle evolving flu mutations. Full story and more reels: https://newsreel.video #news #breaking #health #vaccine #mRNA #flu #Moderna #FDA
Originally reported by The Guardian.
Read the full story →
More in Science
Science
Scien
Science
Tesla and SpaceX will invest $16.8B to start building ‘Terafab’ chip factory in Texas
Science
Scien
Science
Trump administration moves forward with Head Start overhaul, proposing to eliminate regulations
Science
Scien
Science
0 Comments
No comments yet. Be the first.